Role of substance P in an NC/Nga mouse model of atopic dermatitis-like disease

International Archives of Allergy and Immunology

Volumn 133, Issue 4, 2004, Pages 389-397

  Ohmura, Tsuyoshi ^a   Tsunenari, Ichiro ^a   Hayashi, Toshihiro ^a   Satoh, Yayoi ^a   Konomi, Ayako ^a   Nanri, Hirotoshi ^a   Kawachi, Mamoru ^a   Morikawa, Makoto ^a   Kadota, Toshihito ^a   Satoh, Hisashi ^a  

^a NIPPON BOEHRINGER INGELHEIM CO LTD   (Japan)

Author keywords

Allergy; Animal model; Dermatitis; Substance P

Indexed keywords

PICRYL CHLORIDE; SUBSTANCE P;

ALLERGIC REACTION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CELL COUNT; CLINICAL FEATURE; CONTROLLED STUDY; DERMOEPIDERMAL JUNCTION; DISEASE EXACERBATION; DRY SKIN; EDEMA; EOSINOPHIL; ERYTHEMA; EXPERIMENTAL MODEL; GROWTH RETARDATION; LYMPHOCYTIC INFILTRATION; MALE; MAST CELL; MENTAL STRESS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SCRATCHING; SKIN BLEEDING; SKIN DEFECT; SPECIES COMPARISON;

ANIMALS; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; IMMUNOGLOBULIN E; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-4; MALE; MAST CELLS; MICE; PICRYL CHLORIDE; STATISTICS, NONPARAMETRIC; SUBSTANCE P;

EID: 11144354825     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077359     Document Type: Article

References (35)

1. Tsudzuki M, Watanabe N, Wada A, Nakane Y, Hiroi J, Matsuda H: Genetic analyses for dermatitis and IgE hyperproduction in the NC/Nga mouse. Immunogenetics 1997;47:88-90.
2. Hiroi J, Sengoku T, Morita K, Kishi S, Sato S, Ogawa T, Tsudzuki M, Matsuda H, Wada A, Esaki K: Effect of tacrolimus hydrate (FK506) ointment on spontaneous dermatitis in NC/Nga mice. Jpn J Pharmacol 1998;76:175-183.
3. Vestergaard C, Yoneyama H, Matsushima K: The NC/Nga mouse: A model for atopic dermatitis. Mol Med Today 2000;6:209-210.
4. Yagi R, Nagai H, Iigo Y, Akimoto T, Arai T, Kubo M: Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice. J Immunol 2002;168:2020-2027.
5. Okada M, Hirasawa Y, Yoshijima K, Imaeda T, Fujimura T, Nagase T, Kimura H, Kyuki K: Effects of clobestalol propionate, a corticosteroid on hapten-induced dermatitis in SPF NC/Nga mice. Pharmacometrics 2000;59:135-139.
6. Andoh T, Nagasawa T, Satoh M, Kuraishi Y: Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice. J Pharmacol Exp Ther 1998;286:1140-1145.
7. Ostlere LS, Cowen T, Rustin MH: Neuropeptides in the skin of patients with atopic dermatitis. Clin Exp Dermatol 1995;20:462-467.
8. Tobin D, Nabarro G, Baart de la Faille H, van Vloten WA, van der Putte SC, Schuurman HJ: Increased number of immunoreactive nerve fibres in atopic dermatitis. J Allergy Clin Immunol 1992;90:613-622.
9. Sugiura H, Omoto M, Hirota Y, Danno K, Uehara M: Density and fine structure of peripheral nerves in various skin lesions of atopic dermatitis. Arch Dermatol Res 1997;289:125-131.
10. Fantini F, Pincelli C, Romualdi P, Donatini A, Giannetti A: Substance P levels are decreased in lesional skin of atopic dermatitis. Exp Dermatol 1992;1:127-128.
11. Heyer G, Hornstein OP, Handwerker HO: Reactions to intradermally injected substance P and topically applied mustard oil in atopic dermatitis patients. Acta Derm Venereol 1991;71:291-295.
12. Kimyai-Asadi A, Usman A: The role of psychological stress in skin disease. J Cutan Med Surg 2001;5:140-145.
13. Barankin B, DeKoven J: Psychosocial effect of common skin diseases. Can Fam Physician 2002;48:712-716.
14. Buske-Kirschbaum A, Gierens A, Hollig H, Hellhammer DH: Stress-induced immunomodulation is altered in patients with atopic dermatitis. J Neuroimmunol 2002;129:161-167.
15. Singh LK, Pang X, Alexacos N, Letourneau R, Theoharides TC: Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: A link to neurogenic skin disorders. Brain Behav Immun 1999;13:225-239.
16. Toyoda M, Makino T, Kagoura M, Morohashi M: Immunolocalization of substance P in human skin mast cells. Arch Dermatol Res 2000;292:418-421.
17. Lotz M, Vaughan JH, Carson DA: Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988;241:1218-1221.
18. Adamek-Guzik T, Guzik TJ, Bzowska M, Czerniawska-Mysik G, Szmyd D, Miedzobrodzki J, Pryjma J: Selected parameters of the cellular and humoral immunity in atopic dermatitis. Relationship to the severity of the disease. Przegl Lek 2001;58:1029-1033.
19. Kotani M, Matsumoto M, Fujita A, Higa S, Wang W, Suemura M, Kishimoto T, Tanaka T: Persimmon leaf extract and astragalin inhibit development of dermatitis and IgE elevation in NC/Nga mice. J Allergy Clin Immunol 2000;106:159-166.
20. Del Prete G: The concept of type-1 and type-2 helper T cells and their cytokines in humans. Int Rev Immunol 1998;16:427-455.
21. Dong C, Flavell RA: Th1 and Th2 cells. Curr Opin Hematol 2001;8:47-51.
22. Tanaka K, Roberts MH, Yamamoto N, Sugiura H, Uehara M, Mao XQ, Shirakawa T, Hopkin JM: Genetic variants of the receptors for thromboxane A2 and IL-4 in atopic dermatitis. Biochem Biophys Res Commun 2002;292:776-780.
23. Yamazaki F, Aragane Y, Maeda A, Matsushita K, Ueno K, Yudate T, Kawada A, Tezuka T: Overactivation of IL-4-induced activator protein-1 in atopic dermatitis. J Dermatol Sci 2002;28:227-233.
24. Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Morohashi M: Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 2002;147:71-79.
25. Berth-Jones J, Graham-Brown RA: Failure of terfenadine in relieving the pruritus of atopic dermatitis. Br J Dermatol 1989;121:635-637.
26. Hanifin JM: The role of antihistamines in atopic dermatitis. J Allergy Clin Immunol 1990;86:666-669.
27. Wahlgren CF: Itch and atopic dermatitis: Clinical and experimental studies. Acta Derm Venereol Suppl (Stockh) 1991;165:1-53.
28. Wahlgren CF, Hagermark O, Bergstrom R: The antipruritic effect of a sedative and a non-sedative antihistamine in atopic dermatitis. Br J Dermatol 1990;122:545-551.
29. Heyer G, Hornstein OP, Handwerker HO: Skin reactions and itch sensation induced by epicutaneous histamine application in atopic dermatitis and controls. J Invest Dermatol 1989;93:492-496.
30. Giannetti A, Girolomoni G: Skin reactivity to neuropeptides in atopic dermatitis. Br J Dermatol 1989;121:681-688.
31. Andoh T, Katsube N, Maruyama M, Kuraishi Y: Involvement of leukotriene B4 in substance P-induced itch-associated response in mice. J Invest Dermatol 2001;117:1621-1626.
32. Hagermark O, Hokfelt T, Pernow B: Flare and itch induced by substance P in human skin. J Invest Dermatol 1978;71:233-235.
33. Farber EM, Nickoloff BJ, Recht B, Fraki JE: Stress, symmetry, and psoriasis: Possible role of neuropeptides. J Am Acad Dermatol 1986;14:305-311.
34. Gibbs BF, Wierecky J, Welker P., Henz BM, Wolff HH, Grabbe J: Human skin mast cells rapidly release preformed and newly generated TNF-alpha and IL-8 following stimulation with anti-IgE and other secretagogues. Exp Dermatol 2001;10:312-320.
35. Okabe T, Hide M, Koro O, Nimi N, Yamamoto S: The release of leukotriene B4 from human skin in response to substance P: Evidence for the functional heterogeneity of human skin mast cells among individuals. Clin Exp Immunol 2001;124:150-156.